Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing

Explore this paper's citation graph

Summary

It is concluded that current DP mechanisms do not simultaneously improve genomic privacy while retaining desirable clinical efficacy, highlighting the need for new mechanisms that should be evaluated in situ using the general methodology introduced by this work.

Type
article
Published
2014-08-01
Cited by
913
References
50
Access
Open access

Keywords

Dosing, Pharmacogenetics, Warfarin, Computer science, Personalized medicine

References

Cited by

Related papers